Press release
What's driving the Hemophilia Treatment Market growth? Biogen, Biotest AG, CSL Behring, Genentech, Kedrion, Novo Nordisk, Octapharma
Hemophilia Treatment Market
Increasing global prevalence of hemophilia will drive the hemophilia treatment market in the upcoming years. According to the National Hemophilia Foundation, the worldwide incidence of hemophilia is around more than 400,000 and occurs in approximately 1 in 5,000 live male births. Rise in number of people suffering from hemophilia and increasing cases of genetic abnormalities will result in propelling the business growth.
Increase in demand for hemophilia treatment to fulfill the unmet needs of people across the globe will propel the global market growth. According to the National Hemophilia Foundation, over 75% people with hemophilia in the world still receive inadequate or no treatment for hemophilia. The wide range of scope for market penetration and demand for hemophilia treatment will significantly impact the industry growth in future.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2772
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
1. Bayer Healthcare
2. Biogen
3. Biotest AG
4. CSL Behring
5. Ferring B.V.
6. Genentech
7. Kedrion
8. Novo Nordisk
9. Octapharma
10. Pfizer
11. Sanofi SA
12. Swedish Orphan Biovitrum AB
Improving healthcare infrastructure in developing regions of Asia Pacific and Latin America region will augment the hemophilia treatment market growth. Increasing investment in R&D activities, growing government initiatives and healthcare infrastructure will assist in business growth. Moreover, rise in the number of improved infrastructure related to public and private healthcare facilities will foster growth opportunities for hemophilia market.
Lack of awareness among the patients regarding hemophilia and the treatment associated with it will be a major market growth impeding factor. A majority of hemophilic patients live in the developing countries, that has little or no access to hemophilia treatment, leading to increasing number of morbidity and mortality. Lack of awareness among people, low level of recognition and diagnosis of hemophilic patients, and dearth of skilled healthcare professionals will impede the business growth.
Browse Report Summary @ https://www.gminsights.com/industry-analysis/hemophilia-treatment-market
U.S. hemophilia treatment market is estimated to grow at 4.1% during the forecast period. Increasing prevalence of hemophilia in the country, enhanced healthcare infrastructure and recent technological advancements in hemophilia treatment will propel the industry growth. Also, presence of renowned pharmaceutical companies such as Sanofi and Roche in the U.S. will foster the growth of hemophilia market.
Indian market was valued at USD 157.9 million in the year 2018. According to a recent study, it was observed that around 14,000 people suffering from hemophilia are registered at Hemophilia Federation of India. Hemophilia also remains one of the most under diagnosed diseases in India. Increasing prevalence of hemophilia, high cases of under-diagnosed hemophilia cases and improving healthcare infrastructure in the country will result in immense market growth.
Some of the key industry players operating in the global hemophilia treatment market include Swedish Orphan Biovitrum AB, Sanofi SA, Pfizer, Novo Nordisk, Genentech, CSL Behring, Biogen, among other players. Key pharmaceutical companies concentrate on new product launches and development, increased R&D investments and product innovation in order to garner significant revenue.
Hemophilia treatment market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:
Hemophilia Treatment Market by Type, 2014 – 2025 (USD Million)
• Hemophilia A
• Severe
• Moderate
• Mild
• Hemophilia B
• Severe
• Moderate
• Mild
• Others
Hemophilia Treatment Market by Product, 2014 – 2025 (USD Million)
• Recombinant Factor Concentrates
• Factor VIII
• Factor IX
• Plasma-derived Factor Concentrates
• Factor VIII
• Factor IX
• Extended Half-life Products
• Factor VIII
• Factor IX
• Others
Hemophilia Treatment Market by Patient, 2014 – 2025 (USD Million)
• Pediatric
• 0 to 4 years
• 5 to 13 years
• 14 to18 years
• Adult
• 19 to 44 years
• 45+ years
Hemophilia Treatment Market by Treatment, 2014 – 2025 (USD Million)
• Prophylaxis
• On Demand
Hemophilia Treatment Market by Treatment, 2014 – 2025 (USD Million)
• Factor Replacement Therapy
• Non-factor Replacement Therapy
• Others
Hemophilia Treatment Market by Drug Class, 2014 – 2025 (USD Million)
• Vasopressin
• Coagulation Factors
Hemophilia Treatment Market by Route of Administration, 2014 – 2025 (USD Million)
• Injectable
• Nasal Spray
• Others
Hemophilia Treatment Market by End-use, 2014 – 2025 (USD Million)
• Hospitals
• Clinics
• Hemophilia Treatment Centers
• Others
The above information is provided for the following regions/countries:
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Poland
• Hungary
• Czech Republic
• Finland
• Greece
• Ireland
• Portugal
• Sweden
• Switzerland
• Ukraine
• Norway
• Slovakia
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Malaysia
• Philippines
• Thailand
• Vietnam
• Singapore
• Latin America
• Brazil
• Mexico
• Argentina
• Columbia
• Chile
• Venezuela
• Middle East and Africa
• South Africa
• Saudi Arabia
• Egypt
• Iran
• Iraq
• UAE
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com/
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving the Hemophilia Treatment Market growth? Biogen, Biotest AG, CSL Behring, Genentech, Kedrion, Novo Nordisk, Octapharma here
News-ID: 1787835 • Views: …
More Releases from Global Market Insights
Acoustic Diaphragm Market slated to observe traction for polypropylene material …
With a seismic rise in the demand for consumer products such a loudspeakers, mobile phones and earphones, acoustic diaphragm market size is slated to surge in the next five years. Notably, acoustic diaphragm tends to inter-convert mechanical vibration to sounds and has become highly popular in headphones and speakers.
Market penetration of materials such as paper, polycarbonate, polypropylene, carbon fiber and aluminum has become more pronounced in the past several…
How will increasing demand for stainless steel transform the Ferroalloys Market …
One of the recent breakthroughs in the global ferroalloys market is the potential acquisition of Ferro Alloys Corporation by Vedanta- a natural resource company early this year. As per reliable sources, the acquisition is expected to complement Vedanta’s current steel business considering the fact that integration of Ferro manufacturing capabilities would offer the possibility to generate significant efficiencies.
Meanwhile, yet other company, Boston Metal has declared having raised over USD 20…
Polyphenylsulfone Market 2021 | Regional Insights & Growth Forecast To 2025
The polyphenylsulfone market will witness significant expansion with the rise in healthcare concerns and the growing requirement for biocompatible products. Polyphenylsulfone is a high-performance thermoplastic that is amorphous, heat-resistant, and transparent. It showcases high sterilization properties and is widely employed as an alternative for polyetheretheketone and polyaryletherketone. Furthermore, the polymer sees large adoption across various verticals of the healthcare sector to offer superior dimensional stability and higher resistance against…
Cosmetic Contact Lens Market 2021: Industry Growth, Competitive Analysis, Future …
Increasing trend of using colored contact lenses may have a positive impact on cosmetic contact lens market outlook. Rising popularity of customized lenses with attractive colors, shades and textures for improving eye appearance is likely to propel industry size. Proliferation of entertainment, online and social media platforms are helping boost the adoption of such lenses.
Cosmetic contact lenses are available in several colors such as blue, green, brown, hazel, grey, violet…
More Releases for Hemophilia
Hemophilia Market
Hemophilia is an inherited genetic syndrome which impairs body-2019s capability to control blood clotting or coagulation. The episodes of bleeding mainly depend on the severity of hemophilia issue. There are two major kinds of hemophilia namely Hemophilia A & Hemophilia B. Hemophilia A is considered to be five times more prevailing as compared to hemophilia B. Occurrence of hemophilia A is found in one out of five or six thousand…
Hemophilia Therapeutics Pipeline Analysis Overview
The study analysed that the hemophilia pipeline comprises of 53 drug candidates in different stages of development.
The pipeline analysis based on route of administration of active drug candidates showed, that around most of the hemophilia drug candidates are being developed to be administered by intravenous route.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/hemophilia-therapeutics-pipeline-analysis
Most of the pharma and biotech companies are developing the therapeutics for hemophilia in collaboration with educational institutes. In…
Hemophilia B - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Hemophilia B - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia B - Pipeline Review, H1 2017, provides an overview of the Hemophilia B (Hematological Disorders) pipeline landscape.
Hemophilia B is a hereditary bleeding disorder caused by a lack of blood clotting factor IX. Symptoms include…
Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Koval …
ReportsWorldwide has announced the addition of a new report title Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Kovaltry, Feiba), By Type of Hemophilia (Hemophilia A, Hemophilia B), By Treatment (On-Demand, Prophylaxis), By Therapy (Replacement , Immune Tolerance Induction ) Outlook 2022 to its growing collection of premium market research reports.
Hemophilia is an inherited bleeding disorder that slows the blood clotting process. The people suffering from this condition experience prolonged…
In-depth analysis of the Global Hemophilia Market: hemophilia A, hemophilia B, h …
Latest industry research report on: Global Hemophilia Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Request For Sample Report @ http://www.marketresearchreports.biz/sample/sample/1064504
The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market. Hemophilia being an inherited genetic bleeding disorder causes…
Hemophilia Treatment Drugs Market Report 2024
Global Hemophilia Treatment Drugs Market: Overview
The global hemophilia treatment drugs market is presently catering to various sub-types of hemophilia such as hemophilia A, hemophilia B and others such as acquired hemophilia and hemophilia C. The increasing awareness of this disorder and the introduction of innovative ways of managing this disease has opened up several opportunities for the global market in recent years. According to the research report, the global hemophilia…
